Key player · Company profile
Teva Pharmaceutical Industries Ltd.
Named as a key player in 198 of our reports, across 33 regions and countries.
Named as a key player in 198 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 6
Brazil 6
Canada 6
China 6
Ecuador 6
Egypt 6
France 6
Germany 6
Hong Kong 6
India 6
Italy 6
Japan 6
Kenya 6
Malaysia 6
Mexico 6
New Zealand 6
Philippines 6
Russia 6
Saudi Arabia 6
Singapore 6
South Africa 6
Spain 6
Thailand 6
UAE 6
UK 6
US 6| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Atopic Dermatitis Drugs | Pharmaceuticals | $11.2 Bn | 12.2% |
| Epilepsy Drugs | Pharmaceuticals | $9.6 Bn | 3.5% |
| Alexipharmic Drugs | Pharmaceuticals | – | – |
| Alopecia areata | Healthcare Services | – | – |
| Aminoglycosides | Pharmaceuticals | – | – |
| Anti-Nerve Growth Factor | Pharmaceuticals | – | – |
Named as key players in the same markets as Teva Pharmaceutical Industries Ltd. (number of shared markets).
Pfizer Inc.5 shared markets
Sanofi4 shared markets
Novartis AG3 shared markets
AbbVie Inc.2 shared markets
AstraZeneca2 shared markets
Bausch Health Companies Inc.2 shared markets
Bristol-Myers Squibb Company2 shared markets
GlaxoSmithKline plc2 shared markets
Search all reports for Teva Pharmaceutical Industries Ltd. All companies